Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk |
Placebo, Questionnaire Administration, Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 4 mg/each breast/day |
Recruiting |
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer |
Fulvestrant, Letrozole, Palbociclib, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts |
Non-Interventional Study |
Not yet recruiting |
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment |
Enhanced Usual Care, Pathways |
Recruiting |
Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial |
Facilitated advance care planning (in-person or telephonic), Web-based advance care planning |
Active, not recruiting |
Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction |
Conventional Imaging, Educational Intervention, Enhanced Consultation, Questionnaire Administration, Standard of Care Consultation |
Active, not recruiting |
Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer |
Antitumor B |
Active, not recruiting |
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery |
Endoxifen Hydrochloride, Placebo Administration, Questionnaire Administration |
Active, not recruiting |
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens |
Bazedoxifene and Conjugated Estrogens |
Recruiting |
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial |
Biopsy, Biospecimen Collection, Placebo Administration, Urolithin A Supplement |
Recruiting |
Pocket Colposcopy Using CARE Algorithm |
Pocket Colposcope |
Not yet recruiting |
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer |
Polygenic Risk Score (PRS) |
Recruiting |
Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN ) |
Assessment of Therapy Complications, Electronic Health Record Review, Medical Device Usage and Evaluation, Survey Administration |
Active, not recruiting |
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer |
Magnetic resonance imaging (MRI) |
Active, not recruiting |
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer |
Endocrine therapy interruption |
Active, not recruiting |
Prevention of Frailty With Fisetin and Exercise (PROFFi) in Breast Cancer Survivors |
Biospecimen Collection, Educational Intervention, Exercise Intervention, Fisetin, Physical Performance Testing, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
Prevention of Oral DNA Damage by Black Raspberries |
BRB Lozenges |
Recruiting |
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients |
Biospecimen Collection, HPV Self-Collection, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine |
Active, not recruiting |
Problem-Solving Therapy for Cancer Caregivers in Outpatient Palliative Care |
Attention-matched Control, In-depth interviews, Problem-Solving Therapy |
Enrolling by invitation |
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors |
Entecavir, Tenofovir Disoproxil Fumarate, Best Practice, Tenofovir Alafenamide |
Active, not recruiting |